Bringing the fundamentals into focus…
Back to Palvella Therapeutics, Inc.
How Palvella Therapeutics, Inc. stacks up
PVLA · against 390 other Healthcare companies of similar size
Valuation
33/ 100
Below the middle of the pack.
Ranked #269 of 391 · scores higher than 31% of peers
Bars: peers in each 10-point band of the valuation score34 peers with a valuation score of 30–39, including PVLA · Click a bar to see the companies
Why valuation scores 33?
Weighted metrics compared with all Healthcare companies.Mainly because of its earnings yield, which is weaker than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -3.2% vs peer median 1.5%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -1.7% vs peer median 0.0%
- EBITDA yield is not reported, so it is left out of the score.
Metric by metric
Position: dot = PVLA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | PVLA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 380 reported | -3.2% | 1.8% | 27% | 30% | |
| EBITDA yieldHigher is better · 391 reported | Not reported | 4.3% | — | — | 50% |
| Free cash flow yieldHigher is better · 193 reported | -1.7% | -0.5% | 43% | 20% | |
| Book yieldHigher is better · 382 reported | 9.9% | 34.1% | 14% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by valuation score
Top 5 and the companies ranked around PVLA| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 12.9B HKD (≈$1.7B) | 99 | 83 | |
| 1 | 226.3B JPY (≈$1.5B) | 99 | 77 | |
| 1 | 40.2B MXN (≈$2.2B) | 99 | 71 | |
| 264 | 1.2B USD | 36 | 36 | |
| 264 | 3.1B USD | 36 | 53 | |
| 264 | 1.9B USD | 36 | 47 | |
| 269 | 1.2B USD | 33 | ||
| 269 | 2.2B USD | 33 | 48 | |
| 269 | 1.8B USD | 33 | ||
| 269 | 3.3B USD | 33 | 39 | |
| 273 | 1.86T KRW (≈$1.3B) | 32 | 43 | |
| 273 | 1.1B USD | 32 | 61 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score